Structures by: Taourirte M.
Total: 14
5-Acetyl-6-methyl-4-phenyl-1-(prop-2-ynyl)-3,4-dihydropyrimidin-2(1<i>H</i>)-one
C16H16N2O2
IUCrData (2017) 2, 12 x171802
a=22.656(2)Å b=12.2607(12)Å c=10.2189(10)Å
α=90° β=100.363(4)° γ=90°
1-(7-Isopropyl-2,5-dimethyl-8-nitronaphthalen-1-yl)ethanone
C17H19NO3
IUCrData (2017) 2, 3 x170368
a=10.8570(5)Å b=9.0549(4)Å c=14.9550(7)Å
α=90° β=91.006(4)° γ=90°
<i>N</i>-[(1a<i>R</i>,5a<i>R</i>,8<i>R</i>,9a<i>R</i>)-1,1-Dichloro-1a,5,5,7-tetramethyl-1a,2,3,4,5,5a,8,9-octahydro-1<i>H</i>-benzo[<i>a</i>]cyclopropa[<i>b</i>][7]annulen-8-yl]acetamide
C18H27Cl2NO
IUCrData (2017) 2, 4 x170492
a=10.5372(4)Å b=10.5372(4)Å c=29.9710(11)Å
α=90° β=90° γ=120°
5-Acetyl-4-(2,5-dimethoxyphenyl)-6-methyl-1-(prop-2-ynyl)-3,4-dihydropyrimidin-2(1<i>H</i>)-one
C18H20N2O4
IUCrData (2017) 2, 6 x170816
a=8.5948(15)Å b=10.1942(16)Å c=10.2572(17)Å
α=74.930(7)° β=75.306(7)° γ=89.866(7)°
2-Benzamido-<i>N</i>-(2,2-diethoxyethyl)benzamide
C20H24N2O4
Acta Crystallographica Section E (2015) 71, 3 o214-o215
a=8.4901(4)Å b=14.2281(7)Å c=15.3864(7)Å
α=90° β=98.659(4)° γ=90°
Diethyl [(4-bromoanilino)(4-ethynylphenyl)methyl]phosphonate
C19H21BrNO3P
Acta Crystallographica Section C (2013) 69, 10 1157-1163
a=10.9339(7)Å b=16.5179(11)Å c=11.1325(7)Å
α=90.00° β=104.1140(10)° γ=90.00°
Diethyl ((4-chloro-2-methylanilino){4-[2-(trimethylsilyl)ethynyl]phenyl}methyl)phosphonate
C23H31ClNO3PSi
Acta Crystallographica Section C (2013) 69, 10 1157-1163
a=17.3791(16)Å b=14.7131(13)Å c=20.019(3)Å
α=90.00° β=90.4640(10)° γ=90.00°
Diethyl [(4-ethynylphenyl)(naphthalen-2-ylamino)methyl]phosphonate
C23H24NO3P
Acta Crystallographica Section C (2013) 69, 10 1157-1163
a=11.3104(10)Å b=11.5194(10)Å c=17.8485(16)Å
α=82.7030(10)° β=81.9430(10)° γ=64.0350(10)°
4-(4-{[(2-Phenylquinazolin-4-yl)oxy]methyl}-1<i>H</i>-1,2,3-triazol- 1-yl)butan-1-ol hemihydrate
C21H21N5O2,0.5(H2O)
Acta Crystallographica Section E (2011) 67, 8 o2029-o2030
a=11.359(4)Å b=7.694(3)Å c=22.817(7)Å
α=90.00° β=101.111(16)° γ=90.00°
Methyl 2-(3-chlorobenzamido)benzoate
C15H12ClNO3
Acta Crystallographica Section E (2012) 68, 12 o3400-o3401
a=25.7464(10)Å b=6.9203(2)Å c=16.9735(6)Å
α=90.00° β=116.045(2)° γ=90.00°
4-{4-[(4-Oxoquinazolin-3-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}butyl acetate
C17H19N5O3
Acta Crystallographica Section E (2011) 67, 12 o3191
a=10.2546(4)Å b=8.7643(3)Å c=37.5434(13)Å
α=90.00° β=90.00° γ=90.00°
2-({4-[4-(1<i>H</i>-Benzimidazol-2-yl)phenyl]-1<i>H</i>- 1,2,3-triazol-1-yl}methoxy)ethanol
C18H17N5O2
Acta Crystallographica Section E (2012) 68, 6 o1908
a=10.4449(5)Å b=7.7754(4)Å c=20.2119(10)Å
α=90.00° β=99.3540(10)° γ=90.00°
3-{[1-(2,3,5-Tri-<i>O</i>-benzoyl-β-<i>D</i>-ribofuranos-1-yl)- 1<i>H</i>-1,2,3-triazol-4-yl]methyl}quinazolin-4(3<i>H</i>)-one
C37H29N5O8
Acta Crystallographica Section E (2012) 68, 11 o3166
a=11.2646(2)Å b=5.64710(10)Å c=25.7507(4)Å
α=90.00° β=99.5950(10)° γ=90.00°
Diethyl ((4-fluoroanilino){4-[2-(trimethylsilyl)ethynyl]phenyl}methyl)phosphonate
C22H29FNO3PSi
Acta Crystallographica Section C (2013) 69, 10 1157-1163
a=8.9633(7)Å b=11.1726(9)Å c=12.6997(10)Å
α=69.9800(10)° β=87.2630(10)° γ=73.6670(10)°